HTLV-1 can be involved in acceleration of different nonhematological cancers
Journal Title: Journal of Cancer Research & Therapy - Year 2019, Vol 7, Issue 1
Abstract
In the past two decades it has been found that viral proteins might contribute to activation of numerous pathways involved in different types of cancer. Human T-lymphotropic virus 1 (HTLV-1), well known as a cause of T-cell leukemia, was found in patients having different types of cancers. Initiation and development of cancers is usually a multi-year multistep process that starts with initiation of the first somatic mutation and the then the next set of steps with the occurrence of an increasing number of somatic mutations with specific times for each one. Here we suggest a hypothesis: If HTLV-1 virus can infect the nonhematological cell, its viral proteins can work as the agents activating the general cancer-related pathways. This way Tax HTLV-1 protein (and/or other viral proteins) can serve in the similar way as the somatic mutation of specified genes and the presence of Tax can affect the functionality of several pathways that are not yet activated by the timeline of the stages of a “normal” cancer development. For example, the pathways PI3K, p53, TGF-β can be correspondingly be activated and inhibited by Tax before their functional change would appear by the timeline of a “normal” cancer development. The HTLV-1 infection-related KEGG pathway was found when the sets of the most frequently mutated genes for several cancers were analyzed by the DAVID program program (that selects the most probable pathways for a set of selected genes). These findings support the hypotheses that HTLV-1 infection can be a common factor in the development of very different cancers, thus warranting further exploration.
Authors and Affiliations
Valentina L Kouznetsova, Steven Chen, Igor F Tsigelny
Keywords
Related Articles
- EP ID EP534963
- DOI 10.14312/2052-4994.2019-1
- Views 51
- Downloads 0
Can vascular endothelial growth factor C expression be of use in predicting surgical stage or prognosis in vulvar cancer ?
Introduction: Nodal metastasis is a main prognostic factor in vulvar cancer. Increased vascular endothelial growth factor C (VEGF-C) expression has been associated with lymph node metastasis and poor prognosis in many ca...
A retrospective study of survival in breast cancer patients undergoing deuterium depletion in addition to conventional therapies
There is increasing evidence that the heavy isotope of hydrogen, deuterium (D), has a pivotal role in cell signalling and that its depletion through the replacement of normal drinking water with deuterium-depleted water...
Clinical and prognostic significance of plasma fibrinogen in lung cancer
Objectives: Hyperfibrinogenemia is a common problem associated with various carcinomas. The recent studies have shown that high plasma fibrinogen concentration is associated with invasion, growth and metastases of cancer...
Multi-institutional analysis of bioimpedance spectroscopy in the early detection of breast cancer related lymphedema
Background: The purpose of this study was to evaluate bioelectrical impedance spectroscopy’s (BIS) ability to detect and monitor extracellular fluid accumulation of the upper limb as it relates to the extent of loco-regi...
Epifluorescent imaging study of the effect of anti-diabetic drug metformin on colorectal cancer cell lines in vitro
Metformin, a widely used anti-diabetic drug, has recently been associated with inhibition of cell proliferation in multiple cancers. However, it is not clear if the reduction in proliferation on treatment with metformin...